Abstract
Platelet-activating factor (PAF) was discovered in 1972 in relation to allergic reaction as a fluid mediator released from basophils (1), and its structure was determined in 1980 as l-alkyl(octadecyl/hexadecyl)-2-acetyl-sn-glycero-3-phosphocholine (2) (Fig. 9.1). Now PAF is known as a chemical mediator of allergic and inflammatory processes and is thought not to be a constituent of animal tissues but to be newly generated from inflammatory cells in response to a variety of stimuli. PAF has a variety of biological activities such as platelet activation, neutrophil activation, increasing vascular permeability, hypotension, etc. and has the strongest agonist action (10 pM) for platelet aggregation. The name, platelet-activating factor, is based on this biological activity and not on its chemical nature. On the other hand, PAF has recently being found in normal animal tissues without any exogenous or inflammatory stimuli, and its level is variable under physiological conditions (3).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Benveniste, J., Henson, P. M., and Cochrane, C. G., 1972, Leukocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet-activating factor, J. Exp. Med. 136:1356–1377.
Hanahan, D. J., Demopoulos, C. A., Liehr, J., and Pinckard, R. N., 1980, Identification of platelet-activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine, J. Biol. Chem. 255:5514–5516.
Saito, K., Nakayama, R., Yasuda, K., Sugatani, J., and Satouchi, K., in: Platelet-Activating Factor and Diseases (K. Saito and D. J. Hanahan, eds.), International Medical Publishers, Tokyo, pp. 19–35.
Chilton, F. H., Ellis, J. M., Olson, S. C., and Wykle, R. L., 1984, 1-O-Alkyl-2-arach-idonoyl-sn-glycero-3-phosphocholine, J. Biol. Chem. 259:12014–12019.
Snyder, F., 1987, in: Platelet-Activating Factor and Related Lipid Mediators (F. Snyder, ed.), Plenum Press, New York, pp. 89–113.
Satouchi, K., Oda, M., Yasunaga, K., and Saito, K., 1983, Application of selected ion monitoring to determination of platelet-activating factor, J. Biochem. 94:2067–2070.
Ramesha, C. S., and Pickett, W. C., 1986, Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry, Biomed. Environ. Mass Spectrom. 13:107–111.
Yamada, K., Asano, O., Yoshimura, T., and Katayama, K., 1988, Highly sensitive gas chromatographic-mass spectrometric method for the determination of platelet-activating factor in human blood, J. Chromatogr. 433:243–247.
Haroldsen, P. E., and Gaskell, S. J., 1989, Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry, Biomed. Environ. Mass Spectrom. 18:439–444.
Nakayama, R., Yasuda, K., and Saito, K., 1987, Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus, J. Biol. Chem. 262:13174–13179.
Sugatani, J., Lee, D. Y., Hughes, K. T., and Saito, K., 1990, Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: Comparison with bioassay and GC/MS techniques, Life Sci. 46:1443–1450.
Clay, K. L., Murphy, R. C., Andres, J. L., Lynch, J. M., and Henson, P. M., 1984, Structure elucidation of platelet activating factor derived from human neutrophils, Biochem. Biophys. Res. Commun. 121:815–825.
Christman, B. W., and Blair, I. A., 1989, Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry, Biomed. Environ. Mass Spectrom. 18:258–264.
Nakayama, R., Yasuda, K., Satouchi, K., and Saito, K., 1988, in: l-O-Hexadec-l′-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity, Biochem. Biophys. Res. Commun. 151:1256–1261.
Satouchi, K., Oda, M., and Saito, K., 1987, l-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes, Lipids 22:285–287.
Yasuda, K., Satouchi, K., Nakayama, R., and Saito, K., 1988, Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry, Biomed. Environ. Mass Spectrom. 16:137–141.
Nakayama, R., and Saito, K., 1989, Presence of 1-O-alk-l′-enyl-2-O-acetyl glycerophospho-choline (vinyl form of PAF) in perfused rat and guinea pig hearts, J. Biochem. 105:494–496.
Kayganich, K., and Murphy, R. C., 1991, Molecular species analysis of arachidonate containing glycerophosphocholines by tandem mass spectrometry, J. Am. Soc. Mass Spectrom. 2:45–54.
Saito, K., Nakayama, R., Yasuda, K., Satouchi, K., and Sugatani, J., 1990, in: Biological Mass Spectrometry (A. L. Burlingame and J. A. McCloskey, eds.), Elsevier, Amsterdam, pp. 527–547.
Kates, M., in: Techniques of Lipidology, 2nd rev. ed., Elsevier, Amsterdam, pp. 100–111.
Blank, M. L., Robinson, M., and Snyder, F., 1987, in: Platelet-Activating Factor and Related Lipid Mediators (F. Snyder, ed.), Plenum Press, New York, pp. 33–52.
Creer, M. H., Pastor, C., Corr, P. B., Gross, R. W., and Sobel, B. E., 1985, Quantification of choline and ethanolamine phospholipids in rabbit myocardium, Anal. Biochem. 144:65–74.
Saito, K., and Hanahan, D. J. (eds.), 1989, PAF and Diseases, International Medical Publishers, Tokyo.
Kornecki, E., and Ehrlich, Y. H., 1988, Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor, Science 240:1792–1794.
Sugatani, J., Fujimura, K., Miwa, M., Mizuno, T., Sameshima, Y, and Saito, K., 1989, Occurrence of platelet-activating factor (PAF) in normal rat stomach and alteration of PAF level by water immersion stress, FASEB J. 3:65–70.
Nakayama, R., Yasuda, K., Okumura, T., and Saito, K., 1991, Effect of 17β-estradiol on PAF and prostaglandin levels in oophorectomized rat uterus, Biochim. Biophys. Acta 1085:235–240.
Smiley, P. L., Stremler, K. E., Prescott, S. M., Zimmerman, G. A., and Mclntyre, T. M., 1991, Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor, J. Biol. Chem. 266:11104–11110.
O’Flaherty, J. T., Redman, J. F., Jr., Schmitt, J. D., Ellis, J. M., Surles, J. R., Marx, M. H., Piantadosi, C., and Wykle, R. L., 1987, l-O-Alkyl-2-N-methylcarbamyl-glycerophosphocholine: A biologically potent, nonmetabolizable analog of platelet-activating factor, Biochem. Biophys. Res. Commun. 147:18–24.
Sugiura, T., Ojima, T., Fukuda, T., Satouchi, K., Saito, K., and Waku, K., 1991, Occurrence of platelet-activating factor in slugs, J. Lipid Res. 32:1795–1803.
Ramesha, C. S., and Pickett, W. C., 1986, Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear luekocytes depleted of arachidonic acid, J. Biol. Chem. 261:7592–7595.
Ramesha, C. S., and Pickett, W. C., 1986, Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes, J. Biol. Chem. 261:15519–15523.
Sperling, R. I., Robin, J.-L., Kylander, K. A., Lee, T. H., Lewis, R. A., and Austen, K. F., 1987, The effects of n-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes, J. Immunol. 139:4186–4191.
Croft, K. D., Codde, J. P., Barden, A., Vandongen, R., and Beilin, L. J., 1988, Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes, Clin. Exp. Pharmacol. Physiol. 15:517–525.
Triggiani, M., Connell, T. R., and Chilton, F. H., 1990, Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor, J. Immunol. 145:2241–2248.
Horii, T., Satouchi, K., Kobayashi, Y., Saito, K., Watanabe, S., Yoshida, Y, and Okuyama, H., 1991, Effect of dietary linolenate on platelet-activating factor production in rat peritoneal polymorphonuclear leukocytes, J. Immunol. 147:1607–1613.
Cole, M. J., and Enke, C. G., 1991, Direct determination of phospholipid structures in microorganisms by fast atom bombardment triple quadrupole mass spectrometry, Anal. Chem. 63:1032–1038.
Yamada, K., Asano, O., Yoshimura, T., and Katayama K., 1988, Highly sensitive gas chro-matographic-mass spectrometric method for the determination of platelet-activating factor in human blood, J. Chromatogr. 433:243–247.
Caramelo, C., Fernandez-Gallardo, S., Marin-Cao, D., Inarrea, P., Santos, J. C., Lopez-Novoa, J. M., and Crespo, M. S., 1984, Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals, Biochem. Biophys. Res. Commun. 120:789–796.
Grandel, K. E., Farr, R. S., Wanderer, A. A., Eisenstadt, T. C., and Wasserman, S. I., 1985, Association of platelet-activating factor with primary acquired cold urticaria, N. Engl. J. Med. 313:405–409.
Caramelo, C., Fernandez-Gallardo, S., Santos, J. C., Inarrea, P., Sanchez-Crespo, M., Lopez-Novoa, J. M., and Hernando, L., 1987, Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver, Eur. J. Clin. Invest. 17:7–11.
Sakaguchi, K., Masugi, F., Chen, Y-H., Inoue, M., Ogihara, T., Yamada, K., and Yamatsu, I., 1989, Direct evidence of elevated levels of circulating platelet-activating factor in a patient with disseminated intravascular coagulation syndrome, J. Lipid Med. 1:171–173.
Lazanas, M., Demopoulos, C. A., Tournis, S., Koussissis, S., Labrakis-Lazanas, K., and Tsarouhas, X., 1988, Arch. Dermatol. Res. 280:124–126.
Diez, F. L., Nieto, M. L., Fernandez-Gallardo, S., Gijon, M. A., and Crespo, M. S., 1989, Occupancy of platelet receptors for platelet-activating factor in patients with septicemia, J. Clin. Invest. 83:1733–1740.
Camussi, G., Pawlowski, I., Saunders, R., Brentjens, J., and Andres, G., 1987, Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin, J. Lab. Clin. Med. 110:196–206.
Doebber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N., and Shen, T. Y, 1985, Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist Kadsurenone, Biochem. Biophys. Res. Commun. 127:799–808.
Chang, S-W., Feddersen, C. O., Henson, P. M., and Voelkel, N. F., 1987, Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats, J. Clin. Invest. 79:1498–1509.
Billah, M. M., and Johnston, J. M., 1983, Identification of phospholipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine, Boichem. Biophys. Res. Commun. 113:51–58.
Stenton, S. C., Court, E. N., Kingston, W. P., Goadby, P., Kelly, C. A., Duddridge, M., Ward, C., Hendrick, D. J., and Walters, E. H., 1990, Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects, Eur. Respir. J. 3:408–413.
Horii, T., Okazaki, H., Kino, M., Kobayashi, Y., Satouchi, K., and Saito, K., 1991, Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient, Lipids 26:1292–1296.
Arditi, M., Manogue, K. R., Caplan, M., and Yogev, R., 1990, Cerebrospinal fluid cachec-tin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children, J. Infect. Dis. 162:139–147.
Oda, M., Satouchi, K., Ikeda, I., Sakakura, M., Yasunaga, K., and Saito, K., 1990, The presence of platelet-activating factor associated with eosinophil and/or neutrophil accumulations in the pleural fluids, Am. Rev. Respir. Dis. 141:1469–1473.
Christman, B. W., and Blair, I. A., 1989, Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry, Biomed. Environ. Mass Spectrom. 18:258–264.
Sanchez-Crespo, M, Inarrea, P., Alvarez, V., Alonso, F., Egido, J., and Hernando, L., 1983, Presence in normal human urine of a hypotensive and platelet-activating phospholipid, Am. J. Physiol. 244:F706-F711.
Ikeda, I., Oda, M., Sakakura, M., and Yasunaga, K., 1991, Presence of platelet-activating factor in pyuria in humans, Lipids 26:1333–1335.
Minhas, B. S., Robertson, J. L., Kumar, R., Dodson, M. G., and Ricker, D. D., 1991, The presence of platelet-activating factor-like activity in human spermatozoa, Fertil. Steril. 55:372–376.
Parks, J. E., Hough, S., and Elrod, C., 1990, Platelet activating factor activity in the phospholipids of bovine spermatozoa, Biol. Reprod. 43:806–811.
Kumar, R., Harper, M. J. K., and Hanahan, D. J., 1988, Occurrence of platelet-activating factor in rabbit spermatozoa, Arch. Biochem. Biophys. 260:497–502.
Pitton, C., Lanson, M., Besson, P., Fetissoff, F., Lansac, J., Benveniste, J., and Bougnoux, P., 1989, Presence of PAF-acether in human breast carcinoma: Relation to axillary lymph node metastasis, J. Natl. Cancer Inst. 81:1298–1302.
Mallet, A. I., and Cunningham, F. M., 1985, Structural identification of platelet-activating factor in psoriatic scale, Biochem. Biophys. Res. Commun. 126:192–198.
Salem, P., Denizot, Y., Pitton, C., Dulioust, A., Bossant, M-J., Benveniste, J., and Thomas Y., 1989, Presence of PAF-acether in human thymus, FEBS 257:49–51.
Annable, C. R., McManus, L. M., Carey, K. D., and Pinckard, R. N., 1985, Isolation of platelet-activating factor (PAF) from ischemic baboon myocardium, Fed. Proc. 44:1271.
Tokumura, A., Kamiyasu, K., Takauchi, K., and Tsukatani, H., 1987, Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain, Biochem. Biophys. Res. Commun. 145:415–425.
Calignano, A., Cirino, G., Meli, R., and Persico, P., 1988, Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin, J. Pharmacol. Methods 19:89–91.
Angle, M. J., Jones, M. A., McManus, L. M., Pinckard, R. N., and Harper, M. J. K., 1988, Platelet-activating factor in the rabbit uterus during early pregnancy, J. Reprod. Fert. 83:711–722.
Hwang, S., Lam, M-H., Li, C-L., and Shen T-Y., 1986, Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema, Eur. J. Pharmacol. 120:33–41.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Saito, K. (1992). Platelet-Activating Factor and Related Compounds. In: Desiderio, D.M. (eds) Mass Spectrometry. Modern Analytical Chemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1173-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1173-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1175-9
Online ISBN: 978-1-4899-1173-5
eBook Packages: Springer Book Archive